MissionIR Articles
-
MissionIRNewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS, WLDSW) Secures Continuation Patent for Gesture and Voice-Control Interface
Wearable Devices (NASDAQ: WLDS, WLDSW), a technology company specializing in AI-powered touchless sensing wearables, announced the issuance of a continuation patent by the U.S. Patent and Trademark Office, expanding its foundational patent titled “Gesture and Voice-Controlled Interface Device.” The patent enhances protection for the company’s neural interface technologies by introducing a method to identify start…
-
MissionIRNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Petitions FDA to Ban Benzethonium Chloride from Ketamine Products
NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, has filed a Citizen Petition with the FDA requesting the removal of Benzethonium Chloride (BZT) from all ketamine products sold in the U.S. BZT, a quaternary amine preservative, is not Generally Recognized as Safe (GRAS) for parenteral use or Generally Recognized as Safe and Effective (GRASE) for…
-
MissionIRNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Unveils AI Tool to Predict Blood-Brain Barrier Permeability with 94% Accuracy
Lantern Pharma (NASDAQ: LTRN), an AI-driven oncology drug development company, has launched predictBBB.ai(TM), a public AI module that predicts blood-brain barrier (BBB) permeability of small molecules with 94% accuracy, 95% sensitivity, and 89% specificity. Built on billions of molecular data points from Lantern’s proprietary data lake, the platform addresses the pharmaceutical challenge that only 2–6%…
-
MissionIRNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Achieves Biological Efficacy in Phase 2a SGX945 Study for Behçet’s Disease
Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company developing products for rare diseases, has completed its Phase 2a proof of concept study evaluating SGX945 (dusquetide) in Behçet’s Disease, meeting the objective of demonstrating biological efficacy. In the open-label trial, SGX945 achieved a 40% improvement in the primary ulcer endpoint versus a historical placebo group from the…
-
MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Launches Advanced Cryogenic Packaging Initiative to Scale Quantum Processor Development
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, announced a strategic initiative focused on advanced cryogenic packaging to accelerate development of both its gate-model and annealing quantum processors. The effort builds on D-Wave’s superconducting packaging expertise and aims to expand multichip capabilities and manufacturing processes to support larger,…
-
MissionIRNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Launches Enterprise Data Monetization With IBM watsonx.ai-Powered Agents
Datavault AI (NASDAQ: DVLT), a platinum partner in IBM Partner Plus, announced the expanded commercialization of its flagship AI agents, DataScore and DataValue, now embedded with IBM watsonx.ai. Designed to turn enterprise data into financial assets, the tools aim to streamline modeling, risk assessment and pricing strategies across on-premises, cloud and hybrid environments. With generative…
-
MissionIRNewsBreaks – BluSky AI Inc. (OTC: BSAI) Signs LOI to Acquire 15 Acres in Arizona for Modular AI Expansion
BluSky AI (OTC: BSAI), a leading innovator in modular AI infrastructure, signed a Letter of Intent (LOI) to purchase approximately 15 acres of industrial land in Camp Verde, Arizona. The site includes existing electrical infrastructure capable of supporting 1.75 megawatts (MW), with plans to expand to 3.75 MW to meet growing demand. CEO Trent D’Ambrosio…
-
MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Schedules Aug. 13 Call to Discuss Q2 Results and Provide Business Updates
HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care with personalized insights, will hold a conference call Aug. 13, 2025, at 4:30 p.m. Eastern to discuss second-quarter results for the period ended June 30, 2025. The company will also provide updates on regulatory initiatives, commercial-readiness activities and anticipated milestones. CEO Robert Eno…
-
MissionIRNewsBreaks – BluSky AI Inc. (OTC: BSAI) to Acquire Land and 50MW Power Access for Delta Data Center Development
BluSky AI (OTC: BSAI), a modular AI infrastructure innovator, announced it has signed a non-binding letter of intent with Creekstone Energy LLC to acquire 25 acres within the Delta Data Center Development, including access to up to 50 megawatts of scalable power. The site, located within Creekstone’s Delta Gigasite in Utah, will serve as a…
-
MissionIRNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Receives FDA Fast Track Designation for CLD-201 in Soft Tissue Sarcoma
Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company developing targeted genetic medicine delivery therapies, announced that the U.S. Food and Drug Administration granted Fast Track designation to CLD-201 (SuperNova), its allogeneic adipose stem-cell loaded oncolytic virus for treating soft tissue sarcoma. The designation provides opportunities for expedited development, including priority review and accelerated approval.…
-
MissionIRNewsBreaks – Bollinger Innovations, Inc. (NASDAQ: BINI) Completes Name and Ticker Change from Mullen Automotive
Bollinger Innovations (NASDAQ: BINI), an electric vehicle manufacturer, announced that its previously disclosed name change from Mullen Automotive Inc. to Bollinger Innovations, Inc. is effective as of July 28, 2025, along with its new Nasdaq stock symbol “BINI.” The company stated the transition unifies its commercial Class 1, 3 and 4 vehicles under a single…
-
MissionIRNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Appoints Dr. Lee T. Schalop to Board to Bolster AI-Driven Precision Oncology
Lantern Pharma (NASDAQ: LTRN), a clinical-stage biopharmaceutical company leveraging artificial intelligence and genomic data to accelerate oncology drug discovery, announced the appointment of Lee T. Schalop, MD, to its Board of Directors. Dr. Schalop, co-founder and former CEO of Oncoceutics Inc., brings over 20 years of experience in biotechnology leadership and financial markets, with a…
-
MissionIRNewsBreaks – Nutriband Inc. (NASDAQ: NTRB): Innovation Meets Science Through Scalable Platform
Nutriband (NASDAQ: NTRB) is positioning at the forefront of abuse-deterrent drug delivery in advancing its flagship fentanyl patch and buprenorphine candidates. The company combines transdermal innovation with abuse-deterrent science to meet critical public health needs. According to Nurtiband, AVERSA Fentanyl, with the possibility to reach peak annual U.S. sales of $80 to $200 million, holds…
-
MissionIRNewsBreaks – Clene Inc. (NASDAQ: CLNN) Builds Momentum to Bring New Hope to Neuro Patients
Clene (NASDAQ: CLNN), together with its subsidiary Clene Nanomedicine Inc., is preparing to initiate neurofilament biomarker analyses for its lead drug candidate CNM-Au8(R) in ALS, following feedback from the FDA during a recent Type C meeting. Slated for early Q4 2025, the analyses will assess changes in neurofilament light chain (“NfL”)—a recognized marker for neurodegeneration—among…
-
MissionIRNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Tees Up Innovation for the ‘Sport’s New Face’
Newton Golf Company (NASDAQ: NWTG) is delivering innovative products to the dynamic market as a surge in women’s golf participation is reshaping the industry. The company recently released a lighter shaft option, designed to deliver premium performance for golfers of all levels, from weekend enthusiasts to tour professionals. “Newton Golf’s introduction of its lighter shaft further…
-
MissionIRNewsBreaks – BluSky AI Inc. (OTC: BSAI) CEO Featured on IBN’s GotStocks Podcast to Discuss Scalable AI Infrastructure Strategy
BluSky AI (OTC: BSAI) CEO Trent D’Ambrosio was featured on the latest episode of IBN’s GotStocks Podcast, where he outlined the company’s mission to deliver modular, high-performance AI infrastructure with dramatically shortened build times. D’Ambrosio highlighted BluSky’s focus on inference computing and its scalable, adaptive design approach, capable of delivering facilities in 12 to 18…
-
MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Reports Strong Expectations for Quantum Computing-Based Optimization
D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, released findings from a survey conducted with Wakefield Research showing rising enterprise interest in quantum optimization. The survey polled 400 business leaders, defined as logistics or operational managers and decision-makers who make decisions about optimization in their line-of-business. Of the business…
-
MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Wins 2025 Innovation Award for Remote Cardiac Diagnostics
HeartBeam (NASDAQ: BEAT), a medical technology company advancing personalized cardiac care, has received the Innovation Award in Remote Cardiac Diagnostics from the 2025 Medical Device Network Excellence Awards. The honor recognizes HeartBeam’s FDA-cleared 3D ECG technology, which enables clinical-grade arrhythmia diagnostics in non-clinical settings via a compact, cable-free device. The synthesized 12-lead ECG software is…
-
MissionIRNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Secures EU Patent for AI-Designed Cancer Drug LP-284
Lantern Pharma (NASDAQ: LTRN) announced the European Patent Office has issued a notice of allowance for a composition of matter patent covering LP-284, a clinical-stage drug candidate for relapsed or refractory non-Hodgkin’s lymphoma. The patent, expected to grant with exclusivity through 2039, adds to existing IP in the U.S. and Japan and supports global commercialization…
Search Articles
Latest Articles
- GlobalTech Corporation (GLTK) Advances Global Retail Expansion Through Planned Moda in Pelle Acquisition, Supporting AI-Driven Growth Strategy
- Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Committed to Responsible Development as Momentum Builds in the Ambler Mining District
- MissionIRNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) CEO Issues Shareholder Letter Highlighting 2025 Milestones and 2026 Outlook
- MissionIRNewsBreaks – Wearable Devices to Spotlight Neural Interface Breakthroughs and Smart-Glasses Innovations at CES 2026
- MissionIRNewsBreaks – Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Spotlighted as Samarium Supply Risks Intensify